Account-creators
1,040
edits
Difference between revisions of "Diffuse leptomeningeal glioneuronal tumour"
Jump to navigation
Jump to search
Diffuse leptomeningeal glioneuronal tumour (view source)
Revision as of 10:38, 12 November 2020
, 10:38, 12 November 2020→General: Prognosis
Jensflorian (talk | contribs) (→Molecular: Update) |
Jensflorian (talk | contribs) (→General: Prognosis) |
||
| Line 3: | Line 3: | ||
==General== | ==General== | ||
Features: | Features: | ||
*Currently no WHO grade assigned. | *Currently no WHO grade assigned. Molecular class MC-1 corresponds to WHO I, class MC-2 to WHO II/III<ref name="pmid29766299">{{cite journal |vauthors=Deng MY, Sill M, Chiang J, Schittenhelm J, Ebinger M, Schuhmann MU, Monoranu CM, Milde T, Wittmann A, Hartmann C, Sommer C, Paulus W, Gärtner J, Brück W, Rüdiger T, Leipold A, Jaunmuktane Z, Brandner S, Giangaspero F, Nozza P, Mora J, Morales la Madrid A, Cruz Martinez O, Hansford JR, Pietsch T, Tietze A, Hernáiz-Driever P, Stoler I, Capper D, Korshunov A, Ellison DW, von Deimling A, Pfister SM, Sahm F, Jones DTW |title=Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features |journal=Acta Neuropathol |volume=136 |issue=2 |pages=239–253 |date=August 2018 |pmid=29766299 |doi=10.1007/s00401-018-1865-4 |url=}}</ref> | ||
*Low-grade lesion but anaplastic progression reported. | *Low-grade lesion but anaplastic progression reported. | ||
* Previously known as '''Disseminated oligodendroglial-like leptomeningeal tumour''' (abbreviated DOLN) | * Previously known as '''Disseminated oligodendroglial-like leptomeningeal tumour''' (abbreviated DOLN) | ||